These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1270 related articles for article (PubMed ID: 21398042)

  • 1. Does VEGF secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight-junction proteins in central nervous system leukemia?
    Feng S; Huang Y; Chen Z
    Med Hypotheses; 2011 May; 76(5):618-21. PubMed ID: 21398042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins.
    Feng S; Cen J; Huang Y; Shen H; Yao L; Wang Y; Chen Z
    PLoS One; 2011; 6(8):e20599. PubMed ID: 21857898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier.
    Lee SW; Kim WJ; Choi YK; Song HS; Son MJ; Gelman IH; Kim YJ; Kim KW
    Nat Med; 2003 Jul; 9(7):900-6. PubMed ID: 12808449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
    Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
    J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disruption of blood brain-barrier by leukemic cells in central nervous system leukemia].
    Feng SR; Chen ZX; Cen JN; Shen HJ; Wang YY; Yao L
    Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):289-93. PubMed ID: 21729594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Critical roles of matrix metalloproteinases secreted by leukemic cells in the pathogenesis of central nervous system leukemia].
    Feng SR; Chen ZX; Cen JN; Shen HJ; Wang YY; Yao L
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1070-1076. PubMed ID: 28088972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.
    Nico B; Frigeri A; Nicchia GP; Corsi P; Ribatti D; Quondamatteo F; Herken R; Girolamo F; Marzullo A; Svelto M; Roncali L
    Glia; 2003 May; 42(3):235-51. PubMed ID: 12673830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
    Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
    Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels.
    Date I; Takagi N; Takagi K; Tanonaka K; Funakoshi H; Matsumoto K; Nakamura T; Takeo S
    Neurosci Lett; 2006 Oct; 407(2):141-5. PubMed ID: 16973272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
    Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
    Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression.
    Yeh WL; Lu DY; Lin CJ; Liou HC; Fu WM
    Mol Pharmacol; 2007 Aug; 72(2):440-9. PubMed ID: 17513385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of VEGF in an experimental model of cortical micronecrosis.
    Lafuente JV; Bulnes S; Mitre B; Riese HH
    Amino Acids; 2002; 23(1-3):241-5. PubMed ID: 12373544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells.
    Spoerri PE; Afzal A; Li Calzi S; Shaw LC; Cai J; Pan H; Boulton M; Grant MB
    Mol Vis; 2006 Jan; 12():32-42. PubMed ID: 16446700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood-brain barrier/neurovascular unit in health and disease.
    Hawkins BT; Davis TP
    Pharmacol Rev; 2005 Jun; 57(2):173-85. PubMed ID: 15914466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2.
    Lee SW; Kim WJ; Jun HO; Choi YK; Kim KW
    Int J Mol Med; 2009 Feb; 23(2):279-84. PubMed ID: 19148554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C; Förster C
    J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
    Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
    J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine in vitro model of the blood-brain barrier for evaluating drug transport.
    Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH
    Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability.
    Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV
    J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
    Nag S; Venugopalan R; Stewart DJ
    Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.